*Cosmas Rinaldi A. Lesmana,^1,2 Rino A. Gani,² Laurentius A. Lesmana¹

1. Digestive Disease & GI Oncology Center, Medistra Hospital, Jakarta, Indonesia
2. Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Universitas Indonesia, Jakarta, Indonesia
*Correspondence to medicaldr2001id@yahoo.com

Disclosure: The authors have declared no conflicts of interest.
Acknowledgements: The authors would like to thank Prof Ho Khek Yu, President of Asian EUS Group, who has provided an insight into the role of endoscopic ultrasound in pancreato-biliary disorders in Asia.
Received: 28.07.17 Accepted: 06.11.17
Citation: EMJ Gastroenterol. 2017;6[1]:69-74.

Abstract

Fat accumulation in the pancreas, defined as fatty pancreas, is usually an incidental finding during transabdominal ultrasound examination. Fatty pancreas without any significant alcohol consumption is defined as non-alcoholic fatty pancreas disease. Even though its clinical impact is still largely unknown, hypothetically the disease progression could lead to chronic pancreatitis and possibly pancreatic cancer development. Recently, metabolic problems such as diabetes, central obesity, fatty liver, and dyslipidaemia have been considered important risk factors related to non-alcoholic fatty pancreas disease and pancreatic cancer; however, the exact mechanism is not yet fully understood. Early detection and screening for pancreatic cancer in clinical practice is troublesome because of the non-specific symptoms, anatomical location, accuracy of biomarkers in clinical practice, and high risk of radiation and contrast agent exposure from imaging study. Endoscopic ultrasound is still considered the best method for pancreas evaluation and for the screening and diagnosis of pancreatic cancer. However, there is still much debate regarding its cost, availability, and the training experience of the operator.

This article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

The post Non-Alcoholic Fatty Pancreas Disease, Pancreatic Cancer, and Impact of Endoscopic Ultrasound Examination on Screening and Surveillance appeared first on European Medical Journal.